Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Dr. Christian Koch discusses the reasons for the improvement in investor sentiment regarding the biotech sector over the past year. He provides detail on some major milestones on the horizon for BB Biotech’s holdings and explains how the team’s data scientists are using big data and AI to enhance every aspect of the investment process and provide novel insights into developments in the sector.

Interview Edison Group with Dr. Christian Koch

Dr. Christian Koch discusses the reasons for the improvement in investor sentiment regarding the biotech sector over the past year. He provides detail on some major milestones on the horizon for BB Biotech’s holdings and explains how the team’s data scientists are using big data and AI to enhance every aspect of the investment process and provide novel insights into developments in the sector.
14.10.2024 - Christian Koch

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993